News Summary

• Boehringer Ingelheim announced the expansion of its global Computational Innovation footprint with the launch of a new center for AI and machine learning in King’s Cross, London, UK.
• As the company continues to innovate and expand its AI capabilities in pharmaceutical R&D, this significant investment recognizes the UK's commitment to AI and the life sciences sector.
• UK Science Minister, Lord Patrick Vallance, said:“AI is unlocking opportunities to advance discovery in life sciences like never before”